Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

OSI Pharmaceuticals Announces the Results of its Offer to Purchase its 2% Convertible Notes and a Change in the Expiration Time of its Offer to Purchase its 3% Convertible Notes
MarketWatch
Tuesday, July 13, 2010 - 8:58pm
tags:
OSI Pharmaceuticals
FDA Scientists Debate Results Of Glaxo Avandia Study
WSJ
Tuesday, July 13, 2010 - 8:55pm
tags:
GSK, Avandia, diabetes, FDA
ILNS has a big stake in the $20 billion Alzheimer's space
Small Cap Network
Tuesday, July 13, 2010 - 8:45pm
tags:
Intellect Neurosciences, Pfizer, JNJ, Alzheimer's disease
California Supreme Court reinstates price-fixing case against 20 drug companies
news10.net
Tuesday, July 13, 2010 - 8:41pm
tags:
price fixing
Glaxo Said to Pay $460 Million to Settle Avandia Damage Suits
Bloomberg
Tuesday, July 13, 2010 - 12:31pm
tags:
settlements, Avandia, GSK, diabetes
Charles River: Wuxi may add $100M to yearly sales
Yahoo/AP
Tuesday, July 13, 2010 - 12:29pm
tags:
Charles River Laboratories, M&A, WuXi PharmaTech
Guest Post: Advice for the New PhRMA President
InVivo
Tuesday, July 13, 2010 - 12:28pm
tags:
PhRMA
Eli Lilly will shed 170 jobs in manufacturing, quality control
Indianapolis Star, IN
Tuesday, July 13, 2010 - 12:19pm
tags:
Eli Lilly, layoffs, drug manufacturing
Avandia On Trial: Nissen's Prosecution
Forbes
Tuesday, July 13, 2010 - 12:18pm
tags:
Steven Nissen, GSK, FDA, Avandia
How Novartis Vaccines turned fear into function
Fierce Pharma
Tuesday, July 13, 2010 - 11:32am
tags:
Novartis, vaccines, Chiron
Human Genome Sciences signs supply deal for lupus drug Benlysta with Lonza
Yahoo/AP
Tuesday, July 13, 2010 - 11:17am
tags:
Human Genome, partnerships, Lonza, Benlysta
Target Date for Protalix Drug
Yahoo/Zacks.com
Tuesday, July 13, 2010 - 11:16am
tags:
Protalix BioTherapeutics, Gaucher disease, Ulypso
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tuesday, July 13, 2010 - 11:14am
tags:
obsesity, diet drugs, advisory panels, FDA, Qnexa, Vivus, Arena Pharmaceuticals, Contrave, Orexigen
PBMs Win A Big Court Ruling Over Disclosure
Pharmalot
Tuesday, July 13, 2010 - 9:33am
tags:
PBMs
Mass. medical gift law faces possible repeal
CNBC
Tuesday, July 13, 2010 - 9:28am
tags:
Massachusetts, physician gifts
Glaxo Begins Its Defense
Forbes
Tuesday, July 13, 2010 - 9:26am
tags:
GSK, Avandia, diabetes, FDA
Did the Federal Courts Just Legalize Channel Stuffing? One Big Pharma Lawyer Thinks So
BNET Pharma
Tuesday, July 13, 2010 - 9:25am
tags:
channel stuffing, Bristol-Myers Squibb
The Best Investing Ideas in Health Care
Motley Fool
Tuesday, July 13, 2010 - 9:18am
tags:
Biovail, Arena Pharmaceuticals, Neurocrine, Avanir
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tuesday, July 13, 2010 - 8:43am
tags:
FDA, diet drugs, obesity, Vivus, advisory panels, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Pfizer Medicine Price-Fixing Suit Reinstated by California High Court
Bloomberg
Tuesday, July 13, 2010 - 8:41am
tags:
Pfizer, California, price fixing, lawsuits, Canada

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.